Dr. Emily K. Kimaku, MD

Dr. Kimaku practices at Saint Luke's East Hospital in Lee'S Summit, Missouri, part of BJC Health.

Dr. Kimaku's NPI, 1053503425, was assigned on August 9, 2007. Dr. Kimaku holds Missouri license 2011026847.

Dr. Kimaku's primary practice is Saint Luke's East Hospital, at 100 N E Saint Luke's Boulevard, Lee'S Summit, MO 64086 in Jackson County. The practice phone is (816) 347-5000. Dr. Kimaku also practices at Saint Lukes East Hospital, 80 NE St Lukes Blvd, Lee'S Summit, MO 64086.

Dr. Kimaku's primary practice is Saint Luke's East Hospital in Lee'S Summit, Missouri, part of BJC Health. Dr. Kimaku is also affiliated with Saint Luke's Hospital of Kansas City. The medical group on file is Saint Luke's Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kimaku practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Kimaku's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Kimaku's licenses on file in 2 states: Missouri and South Dakota.

CMS data shows 668 Medicare services from Dr. Kimaku across 5 procedure codes in 2024, for 295 Medicare patients. Medicare paid $58,079 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 295 Medicare patients who saw Dr. Kimaku in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kimaku's median patient age at 76, with 58% women.

In 2024, Dr. Kimaku wrote 464 Medicare Part D claims for 142 patients. 80% of them were for generic drugs. CMS names the drug for 225 of them, across 10 drugs with 11 or more claims each, at $19,792 in total drug cost. In 2023, CMS named 208 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kimaku for performance year 2024, reported as part of a group. Dr. Kimaku accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Kimaku from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $12.